Partner Headlines - WCRX

  1. Actavis, Forest Labs Join Forces in $25B Deal

    FoxBusiness
  2. Stocks Fall In Mixed Volume; MercadoLibre Breaks Out

    IBD
  3. Stocks Back Off In Mixed Volume; Celgene Hits New High

    IBD
  4. Actavis, Warner Chilcott Receive FTC Clearance for Actavis' Proposed ...

    Benzinga
  5. Top 4 Mid-Cap Stocks In The Drug Manufacturers-Other Industry ...

    Benzinga
  6. Report: Roche Lines up $15B in Debt to Buy BioMarin

    FoxBusiness
  7. Drug Firm Actavis Eyes Growth From A Buyout, Lidoderm

    IBD
  8. Stocks Ease In Light Trade; Ulta Beauty Earnings On Deck

    IBD
  9. Actavis, Warner Chilcott Take Another Step Forward

    IBD
  10. Akorn To Buy Hi-Tech Pharmacal; Both Stocks Jump

    IBD
  11. Actavis Holds Tight, In Buy Area From 133.10 Entry

    IBD
  12. Actavis Wins Approval for Pending Warner Chilcott Purchase in ...

    Benzinga
  13. Actavis Receives Approval from French Competition Authority for ...

    Benzinga
  14. My 5 Favorite High Beta Health Care Dividend Stocks

    GuruFocus
  15. Actavis In Buy Range; Kors, Regeneron Set Up In Bases

    IBD
  16. Actavis Earnings Top Views As It Works To Close Acquisition

    IBD
  17. Stocks Slip Into Red Zone; Wal-Mart Down In Heavy Trade

    IBD
  18. Morgan Stanley Warns Warner Chilcott's DELZICOL 'May Not Qualify ...

    Benzinga
  19. Warner Chilcott Announces FDA Approval of DELZICOL

    Benzinga
  20. Benzinga's M&A Chatter for Wednesday January 30, 2013

    Benzinga
  21. Santarus Wins Drug Approval, Offers Bullish Guidance

    IBD
  22. Weekly Guru Bargains Highlights: WCRX, IOC, QCOR, PWE, PGH

    GuruFocus
  23. Weekly Guru Bargains Highlights: BIG, RATE, WCRX, BPT, MCP

    GuruFocus
  24. Top 4 Mid-Cap Stocks In The Drug Manufacturers-Other Industry ...

    Benzinga
  25. 4 International Stocks at 52-Week Lows - December 2012 Edition

    GuruFocus
  26. Your Kid's Acne Medicine Seem Pricy? It Is, and Here's Why -- ...

    YCharts
  27. UPDATE: Jefferies & Company Reiterates Buy Rating, Lowers PT ...

    Benzinga
  28. Warner Chilcott Ltd. Reports Operating Results (10-Q)

    GuruFocus
  29. US Stock Futures Flat Ahead Of Economic Data

    Benzinga
  30. Earnings Scheduled For November 9, 2012

    Benzinga
  31. UPDATE: Cantor Fitzgerald Upgrades Warner Chilcott to Buy on ...

    Benzinga
  32. Weekly Guru Bargains Highlights: WCRX, NIHD, EBR, CAJ, CIG

    GuruFocus
  33. Warner Chilcott (WCRX) Loses 9.7% on Details of Insider Stock ...

    MarketIntelligenceCenter
  34. Zillow and Others Making Secondary Offerings (BBEP, HLS, MERU)

    Benzinga
  35. Stocks On Track For Upbeat Open On ECB, Economic News

    IBD
  36. Warner Chilcott

    IBD
  37. Warner Chilcott Reports Secondary Equity Offering; Senior Management ...

    Benzinga
  38. Health Care Sector Wrap

    FoxBusiness
  39. UPDATE: Morgan Stanley Downgrades Warner Chilcott to Underweight

    Benzinga
  40. Warner Chilcott Announces $4 per Share Special Dividend

    Benzinga
  41. UPDATE: Goldman Sachs Reinstates Coverage on Warner Chilcott ...

    Benzinga
  42. Warner Chilcott (WCRX) Loses 7.8% After Buyout Talks End

    MarketIntelligenceCenter
  43. Stocks End Little Changed As Volume Dips

    IBD
  44. McDonald's, Polo Ralph Lauren Among Stocks Down on High Volume ...

    FoxBusiness
  45. Stocks Open Modestly Lower; Express Scripts Surges

    IBD
  46. UPDATE: Canaccord Genuity Reduces PT to $77 on Warner Chilcott

    Benzinga
  47. Warner Chilcott Ltd. Reports Operating Results (10-Q)

    GuruFocus
  48. Earnings Scheduled For August 3, 2012

    Benzinga
  49. Top 4 Mid-Cap Stocks In The Drug Manufacturers-Other Industry ...

    Benzinga
  50. Health Care Sector Wrap

    FoxBusiness
  51. Mead Johnson Nutrition, WellPoint Among Stocks Down on Above-average ...

    FoxBusiness
  52. Questcor Up On Plans To Expand Acthar To New Markets

    IBD
  53. Benzinga's M&A Chatter for Monday May 14, 2012

    Benzinga
  54. Earnings Scheduled For May 4

    Benzinga
  55. Option Activity Could Signal Imminent Warner Chilcott Deal

    Benzinga
  56. Warner Chilcott (WCRX) Gains 14.1% on Exploration of Strategic ...

    MarketIntelligenceCenter
  57. Warner Chilcott jumped

    IBD
  58. UPDATE: Goldman Sachs Downgrades Warner Chilcott to Neutral

    Benzinga
  59. Warner Chilcott Ltd. Reports Operating Results (10-K)

    GuruFocus
  60. Low PE Socks from RS Investment Management

    GuruFocus
  61. Low PE Stocks from RS Investment Management

    GuruFocus
  62. Selected Low-P/E Health Care Picks from Edward Owens

    GuruFocus
  63. Citigroup Maintains Buy, $24 Target on Warner Chilcott

    Benzinga
  64. Warner Chilcott Announces Decision on Appeal of DORYX Preliminary ...

    Benzinga
  65. Notable Put Options Activity in Warner Chilcott

    Benzinga
  66. Novo, Valeant, Other Foreign Drugmakers Behave Well

    IBD
Trading Center